Projected number of people with diagnosed Type 2 diabetes in Germany in 2040.
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
accepted:
16
01
2019
pubmed:
20
1
2019
medline:
4
9
2020
entrez:
20
1
2019
Statut:
ppublish
Résumé
To project the number of people with Type 2 diabetes in Germany between 2015 and 2040. Based on data from 65 million insurees of the German statutory health insurance, we projected the age-specific prevalence of diabetes using mathematical relations between prevalence, incidence rate and mortality. We compared several scenarios regarding temporal trends in the incidence and mortality rate. The projected age-specific prevalence was applied to the projected age structure of the German population between 2015 and 2040 to calculate the number of people with Type 2 diabetes. Application of current age-specific prevalence estimates to the projected age structure in 2040, although ignoring temporal trends in incidence and mortality, yielded an increase in the number of Type 2 diabetes cases from 6.9 million in 2015 to 8.3 million (+21%) in 2040. More realistic scenarios that account for decreasing mortality rates and different trends in the incidence rates project between 10.7 million (+54%) and 12.3 million (+77%) Type 2 diabetes cases in 2040. For the first time, we projected the number of future Type 2 diabetes cases for the whole adult population in Germany. The results indicate a relative increase in the number of Type 2 diabetes cases of between 54% and 77% from 2015 to 2040. Temporal trends in the incidence rate are the main drivers of this increase. Simply applying current age-specific prevalence to the future age structure probably underestimates the future number of Type 2 diabetes cases.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1217-1225Informations de copyright
© 2019 Diabetes UK.
Références
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378: 31-40.
Heidemann C, Scheidt-Nave C. Prevalence, incidence and mortality of diabetes mellitus in adults in Germany - a review in the framework of the Diabetes Surveillance. J Health Monit 2017; 2: 98-121.
Tamayo T, Brinks R, Hoyer A, Kuß O, Rathmann W. The prevalence and incidence of diabetes in Germany: an analysis of statutory health insurance data on 65 million individuals from the years 2009 and 2010. Dtsch Arztebl Int 2016; 113: 177-182.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211-1259.
Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W. Burden of mortality attributable to diagnosed diabetes: a nationwide analysis based on claims data from 65 million people in Germany. Diabetes Care 2017; 40: 1703-1709.
Jacobs E, Hoyer A, Brinks R, Icks A, Kuß O, Rathmann W. Healthcare costs of Type 2 diabetes in Germany. Diabet Med 2017; 34: 855-861.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-281.
Brinks R, Tamayo T, Kowall B, Rathmann W. Prevalence of type 2 diabetes in Germany in 2040: estimates from an epidemiological model. Eur J Epidemiol 2012; 27: 791-797.
Braun A, Wasem J, Biermann J, Farrenkopf N, Jahn R, Lux G et al. Zukünftige medizinische Bedarfe vor dem Hintergrund des demographischen Wandels (S5) - im Rahmen des Nationalen Strategieprozesses „Innovationen in der Medizintechnik”. Düsseldorf: VDI Technologiezentrum, 2012. Available at http://www.strategieprozess-medizintechnik.de/sites/default/files/S5_Medizinische_Bedarfe_Studie.pdf Last accessed 29 January 218.
Wilke T, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F. Inzidenz und Prävalenz von Diabetes mellitus Typ 2 in Deutschland. Dtsch Med Wochenschr 2013; 138: 69-75.
Ramos AL, Hoffmann F. Kassenunterschiede bei chronischen Rückenschmerzen und Gelenkerkrankungen. Z Rheumatol 2017; 76: 238-244.
Statistisches Bundesamt. Bevölkerung Deutschlands bis 2060 - Tabellenband - Ergebnisse der 13. koordinierten Bevölkerungsvorausberechnung. Wiesbaden, 2015. Available at https://www.destatis.de/DE/Publikationen/Thematisch/Bevoelkerung/VorausberechnungBevoelkerung/BevoelkerungDeutschland2060.html Last accessed 29 January 2018.
Röckl S, Brinks R, Baumert J, Paprott R, Du Y, Heidemann C et al. All-cause mortality in adults with and without type 2 diabetes: findings from the national health monitoring in Germany. BMJ Open Diabetes Res Care 2017; 5: e000451.
Brinks R, Landwehr S. Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany. Theor Popul Biol 2014; 92: 62-68.
Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K; Steering Group of the National Diabetes Register. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia 2008; 51: 2187-2196.
Gregg EW, Cheng YJ, Srinivasan M, Lin J, Geiss LS, Albright AL et al. Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data. Lancet 2018; 1391: 2430-2440.
Goffrier B, Schulz M, Bätzing-Feigenbaum J. Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas-Bericht 2017; 10.20364/VA-17.03.
Carstensen B, Borch-Johnsen K. Changes in diabetes prevalence: decreasing mortality or increasing incidence? Presentation at the annual meeting of the European Diabetes Epidemiology Group (EDEG), Potsdam, 2013. Available at http://bendixcarstensen.com/DMreg/Prevalence/Prev-EDEG-2013-BxC-handout.pdf Last accessed 29 January 2018.
Lind M, Garcia-Rodriguez LA, Booth GL, Cea-Soriano L, Shah BR, Ekeroth G et al. Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study. Diabetologia 2013; 56: 2601-2608.
Gregg EW, Cheng YJ, Saydah S, Cowie C, Garfield S, Geiss L et al. Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006 - findings from the National Health Interview Survey. Diabetes Care 2012; 35: 1252-1257.
Schienkiewitz A, Mensink G, Kuhnert R, Lange C. Overweight and obesity among adults in Germany. J Health Monitor 2017; 2: 20-27.
Paprott R, Mensink GBM, Schulze MB, Thiele S, Mühlenbruch K, Scheidt-Nave C et al. Temporal changes in predicted risk of type 2 diabetes in Germany: findings from the German Health Interview and Examination Surveys 1997-1999 and 2008-2011. BMJ Open 2017; 7: e013058.
Green A, Sortsø C, Jensen PB, Emneus M. Incidence, morbidity, mortality, and prevalence of diabetes in Denmark, 2000-2011: results from the Diabetes Impact Study 2013. Clin Epidemiol 2015; 7: 421.
Abouzeid M, Wikström K, Peltonen M, Lindström J, Borodulin K, Rahkonen O et al. Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972-2007. Eur J Epidemiol 2015; 30: 649-659.
Read SH, Kerssens JJ, McAllister DA, Colhoun HM, Fischbacher CM, Lindsay RS et al. Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. Diabetologia 2016; 59: 2106-2113.
Jansson S, Fall K, Brus O, Magnuson A, Wändell P, Östgren CJ et al. Prevalence and incidence of diabetes mellitus: a nationwide population-based pharmaco-epidemiological study in Sweden. Diabet Med 2015; 32: 1319-1328.
Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle, WA: Institute for Health Metrics and Evaluation, 2017.
Boerma T, Victora C, Abouzahr C. Monitoring country progress and achievements by making global predictions: is the tail wagging the dog? Lancet 2018; 392: 607-609.
Boyle JP, Honeycutt AA, Narayan KMV, Hoerger TJ, Geiss LS, Chen H et al. Projection of diabetes burden through 2050 - impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24: 1936-1940.
Magliano DJ, Shaw JE, Shortreed SM, Nusselder WJ, Liew D, Barr ELM et al. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008; 51: 2179-2186.
Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes - estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
International Diabetes Federation. IDF Diabetes Atlas (7th edition). Brussels: IDF, 2015. Available at https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/13-diabetes-atlas-seventh-edition.html Last accessed 29 January 2018.
Heidemann C, Du Y, Paprott R, Haftenberger M, Rathmann W, Scheidt-Nave C. Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997-1999 and 2008-2011. Diabet Med 2016; 33: 1406-1414.
Brinks R, Hoyer A. Illness-death model: statistical perspective and differential equations. Lifetime Data Anal 2018; 24: 743-754.